S. Stryker

发表

Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies

W. Langeberg, W. Schoonen, M. Eisen, 2016, International Journal of Hematology.

Prevalence of patients with nonmetastatic prostate cancer on androgen deprivation therapy in the United States.

Shuling Li, A. Liede, T. Arneson, 2013, Urology.

Health Outcomes Research Prevalence of Patients With Nonmetastatic Prostate Cancer on Androgen Deprivation Therapy in the United States

Shuling Li, A. Liede, T. Arneson, 2013 .

Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level

M. Bensink, P. K. Morrow, Barbara Somlo, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Estimated number of prevalent cases of metastatic bone disease in the US adult population

Shuling Li, E. Weinhandl, T. Arneson, 2012, Clinical epidemiology.

A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation.

J. Vose, A. Nademanee, J. Fay, 1998, Blood.

Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data

D. Pappas, G. Kricorian, N. Accortt, 2020, Rheumatology International.

Summary of worldwide pediatric malignancies reported after exposure to etanercept

P. McCroskery, D. Zack, D. Lovell, 2010, Pediatric rheumatology online journal.

Patient-Reported Nausea and Fatigue Related to Methotrexate: A Prospective, Self-Controlled Study in the ArthritisPower® Registry

J. Curtis, H. Yun, G. Kricorian, 2021, Rheumatology and Therapy.

Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA–B27, and Equal Sex Representation in Sacroiliitis

D. Collier, M. Stoll, R. Matsouaka, 2020, Arthritis care & research.

Population-based study of giant cell tumor of bone in Sweden (1983-2011).

A. Liede, P. Sobocki, J. Engellau, 2016, Cancer epidemiology.

The effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic review

G. Lyman, D. Weycker, M. Reiner, 2017, Supportive Care in Cancer.

Use of prophylactic growth factors and antimicrobials in elderly patients with cancer: a review of the Medicare database

A. Collins, Jiannong Liu, Shuling Li, 2017, Supportive Care in Cancer.

Regional variation and challenges in estimating the incidence of giant cell tumor of bone.

Steven S. Wong, A. Liede, P. Sobocki, 2014, The Journal of bone and joint surgery. American volume.

Renal impairment, hemoglobinuria, and hemoglobinemia among patients with idiopathic thrombocytopenic purpura

S. Cha, Sean Zhao, V. Gastañaga, 2011, American journal of hematology.

A Systematic Literature Review and Meta-Analysis of the Risk of Thromboembolic Events in Patients with Immune Thrombocytopenia (ITP) in Observational Studies.

W. Langeberg, W. Schoonen, M. Eisen, 2012 .

The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes.

N. Casadevall, J. Rossert, D. Kemeny, 2005, Kidney international.

Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin

C. Yee, G. Noel, P. Gerbino, 2002, The Pediatric infectious disease journal.

Time‐Varying Association of Rheumatoid Arthritis Disease Activity to Subsequent Cardiovascular Risk

D. Solomon, L. Harrold, H. Guan, 2022, ACR open rheumatology.

Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for Romiplostim

H. Sørensen, M. Nørgaard, S. Bahmanyar, 2019, EClinicalMedicine.

Mortality among women diagnosed with stage II or III breast cancer based on SEER-Medicare data.

A. Collins, Jiannong Liu, Shuling Li, 2014, Journal of Clinical Oncology.

Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry

D. Pappas, G. Kricorian, N. Accortt, 2020, ACR open rheumatology.

Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry

P. Mease, D. Collier, M. Gharaibeh, 2021, Arthritis Research & Therapy.

Castration resistance and high-risk disease among nonmetastatic (M0) prostate cancer (PC) patients on androgen deprivation therapy (ADT).

J. Adams, A. Liede, Paul A. Smith, 2012 .

Real‐World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

A. Ogdie, P. Mease, D. Collier, 2023, ACR open rheumatology.

Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry

D. Collier, S. Balevic, T. Phillips, 2023, RMD Open.

Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry

C. Sandborg, L. McAllister, Y. Zhang, 2021, Pediatric Rheumatology.

Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population‐based cohort study

M. Nørgaard, S. Bahmanyar, C. Christiansen, 2016, British Journal of Haematology.

Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population‐based cohort study

M. Nørgaard, S. Bahmanyar, C. Christiansen, 2016, British journal of haematology.

Examining the potential direct cardiovascular benefit of tumor‐necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analyses

L. Harrold, D. H. Solomon, H. Guan, 2022, Pharmacoepidemiology and drug safety.

Estimating high-risk castration resistant prostate cancer (CRPC) using electronic health records.

A. Liede, K. Cetin, R. Hernandez, 2015, The Canadian journal of urology.